metformin has been researched along with Blood Protein Disorders in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Blood Protein Disorders: Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sachs, BA | 1 |
| Bardfeld, PA | 1 |
| Bodian, JE | 1 |
| Sugarman, LA | 1 |
| Hellman, L | 1 |
1 trial available for metformin and Blood Protein Disorders
| Article | Year |
|---|---|
Liver scan in hyperlipoproteinemia.
Topics: Adult; Aged; Aspartate Aminotransferases; Blood Protein Disorders; Blood Protein Electrophoresis; Ch | 1974 |